NY Times Challenges Trump Administration Subpoenas Over Air Force One Report 
xAI Sues Man for Allegedly Using Grok to Generate AI Child Abuse Deepfakes 
SEB Q2 Profit Rises on Strong Lending, Record Fee Income, Announces New Share Buyback 
BHP Q4 Iron Ore Output Rebounds as Copper Prices Boost Revenue 
ASML Raises 2026 Outlook as AI Chip Demand Lifts Q2 Earnings 
Stripe, Advent Offer $53 Billion Deal to Acquire PayPal: Reuters 
Volkswagen Launches €28,000 ID. Cross EV as Europe’s Electric Vehicle Demand Accelerates 
Genesis Minerals to Acquire Vault in A$5.6 Billion Deal After Regis Withdraws 
Richemont Q1 Sales Beat Forecast as Cartier Demand Drives Strong Growth 
Apple Intelligence Cleared for China as Alibaba and Baidu AI Power iPhone Features 
SoftBank Corp Partners With Sierra to Expand AI Customer Support Across Japan 
SpaceX Stock Falls Below IPO Price as Investors Weigh Losses and Lockup Expiry 
Yaskawa Electric Shares Slide as Weak Profit Overshadows Strong AI Demand 
Rio Tinto Reports Strong Q2 Iron Ore Sales, Maintains 2026 Production Outlook 
SK Hynix Stock Soars as AI Memory Demand Outlook Fuels Chip Rally 
DeepSeek Eyes China IPO as AI Startup Seeks $71 Billion Valuation in New Funding Round 
Paramount-Warner Bros. Discovery Merger Faces Lawsuit From 12 States 
NEW YORK, Jan. 21, 2016 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of Nobilis Health Corp. (“Nobilis”) (NYSE MKT:HLTH) between April 2, 2015 and January 6, 2016.
You are hereby notified that a securities class action lawsuit has been commenced in the USDC for the Southern District of Texas on behalf of Nobilis shareholder. If you purchased or otherwise acquired Nobilis securities between April 2, 2015 and January 6, 2016, your rights may be affected by this action. To get more information go to:
http://zlk.9nl.com/nobilis-health
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
The complaint alleges that throughout the Class Period defendants issued materially false and misleading statements to investors and/or failed to disclose that: (1) Nobilis’ financial statements contained numerous errors concerning the classification of warrants and options, business combination accounting, share-based compensation, and other financial and operating results; (2) Nobilis overstated its net income for the year ended December 31, 2014 by more than $4 million; (3) Nobilis overstated its net income for the quarter ended March 31, 2015 by more than $3.27 million; and (4) as a result, defendants’ statements about Nobilis’ business, operations, and prospects were false and misleading and/or lacked a reasonable basis.
If you suffered a loss in Nobilis you have until March 21, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.
Levi & Korsinsky, LLP Joseph E. Levi, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com
